Drugs / APC 111 MP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00242281 | Nov 2005 → Jul 2006 | streptococcal sore throat, tonsillitis | Advancis Pharmaceutical Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APC 111 MP | “APC 111 MP Tablet, 775 mg tablet, given orally (PO)once daily (QD) for 10 days” NCT00242281 ↗ |
| Route | Oral | “given orally (PO)once daily (QD)” NCT00242281 ↗ |